Live Breaking News & Updates on Shom goel

Stay informed with the latest breaking news from Shom goel on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Shom goel and stay connected to the pulse of your community

Drug offers new hope for Australians with breast cancer

Patients at high risk of their breast cancer returning will soon have access to a treatment that could prevent just that. For some a re-diagnosis is their biggest fear, which is why improved access to a key drug is considered an important step.

Australia , Australian , Australians , Shom-goel , Mark-butler , Siobhan-mcguiness , Peter-maccallum-cancer-centre , Peter-maccallum-cancer , Pharmaceutical-benefits-scheme , Minister-mark-butler ,

Enzyme-targeting drug stops tumour growth in multiple cancers

An enzyme critically associated with tumour growth has long been a target for researchers, but until now it has been difficult to successfully inhibit it.

Peter-mac , Patrick-roberts , Incyclix-bio , Shom-goel , Peter-maccallum-cancer-centre , Associate-professor-shom-goel , Cancer , Eter-maccallum-cancer-centre , Umours , Dk2 , Nzyme , Ncyclix-bio

Selective CDK2 inhibitor drug can stop cancer growth, animal study suggests

Selective CDK2 inhibitor drug can stop cancer growth, animal study suggests
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Shom-goel , Peter-mac , Patrick-roberts , Catherine-dietrich , Incyclix-bio , Cancer-discovery , Associate-professor-shom-goel ,

Continuing CDK4/6 Inhibitor Beyond Progression No Help in Metastatic Breast Cancer

Prior therapy, baseline mutations confound results; 'intriguing' benefit with PD-L1 inhibitor

Boston , Massachusetts , United-states , Australia , Melbourne , Victoria , San-antonio , Texas , Dana-farber-cancer-institute , Erica-mayer , Charles-bankhead , Shom-goel

$8M from Snow Medical Research Foundation to improve outcomes for breast cancer patients

Some of the cancer cells Dr Goel is working on as part of his research to explain why some cancers relapse years after we thought they were cured. A

Australia , Melbourne , Victoria , Sydney , New-south-wales , Australian , Marina-pajic , Shom-goel , James-mccluskey , Melanie-eckersley-maslin , University-of-melbourne , Peter-maccallum-cancer-centre